Skip to main content

. 1968 Jul;53(1):27–45.

Study of chloroquine toxicity and a drug-induced cerebrospinal lipodystrophy in swine.

C A Gleiser, W W Bay, T W Dukes, R S Brown, W K Read, K R Pierce

PMCID: PMC2013449 PMID: 4297587

Images in this article

Figs. 1-4
on p.39

Fig. 10
on p.41

Fig. 11
on p.42

Fig. 12
on p.42

Fig. 13
on p.43

Fig. 14
on p.43

Fig. 15
on p.43

Fig. 16
on p.43

Fig. 17
on p.44

Fig. 18
on p.44

Fig. 19
on p.44

Fig. 20
on p.44

Fig. 21
on p.45

Fig. 22
on p.45

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BAGNALL A. W. The value of chloroquine in rheumatoid disease: a four-year study of continuous therapy. Can Med Assoc J. 1957 Aug 1;77(3):182–194. [PMC free article] [PubMed] [Google Scholar]
BERNSTEIN H. N., GINSBERG J. THE PATHOLOGY OF CHLOROQUINE RETINOPATHY. Arch Ophthalmol. 1964 Feb;71:238–245. doi: 10.1001/archopht.1964.00970010254019. [DOI] [PubMed] [Google Scholar]
DALE A. J., PARKHILL E. M., LAYTON D. D. STUDIES ON CHLOROQUINE RETINOPATHY IN RABBITS. JAMA. 1965 Jul 19;193:241–243. doi: 10.1001/jama.1965.03090030063026. [DOI] [PubMed] [Google Scholar]
DUBOIS E. L. Systemic lupus erythematosus: recent advances in its diagnosis and treatment. Ann Intern Med. 1956 Aug;45(2):163–184. doi: 10.7326/0003-4819-45-2-163. [DOI] [PubMed] [Google Scholar]
Eadie M. J., Ferrier T. M. Chloroquine myopathy. J Neurol Neurosurg Psychiatry. 1966 Aug;29(4):331–337. doi: 10.1136/jnnp.29.4.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
GOLDMAN L., COLE D. P., PRESTON R. H. Chloroquine diphosphate in treatment of discoid lupus erythematosus. J Am Med Assoc. 1953 Aug 8;152(15):1428–1429. doi: 10.1001/jama.1953.63690150002009a. [DOI] [PubMed] [Google Scholar]
GOLDMAN L., PRESTON R. H. Reactions to chloroquine observed during the treatment of various dermatologic disorders. Am J Trop Med Hyg. 1957 Jul;6(4):654–657. doi: 10.4269/ajtmh.1957.6.654. [DOI] [PubMed] [Google Scholar]
HOBBS H. E., CALNAN C. D. The ocular complications of chloroquine therapy. Lancet. 1958 Jun 7;1(7032):1207–1209. doi: 10.1016/s0140-6736(58)91911-1. [DOI] [PubMed] [Google Scholar]
HOBBS H. E., CALNAN C. D. Visual disturbances with antimalarial drugs, with particular reference to chloroquine keratopathy. Arch Dermatol. 1959 Nov;80:557–563. doi: 10.1001/archderm.1959.01560230043008. [DOI] [PubMed] [Google Scholar]
HOBBS H. E., SORSBY A., FREEDMAN A. Retinopathy following chloroquine therapy. Lancet. 1959 Oct 3;2(7101):478–480. doi: 10.1016/s0140-6736(59)90604-x. [DOI] [PubMed] [Google Scholar]
Hobbs H. E., Eadie S. P., Somerville F. OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE. Br J Ophthalmol. 1961 Apr;45(4):284–297. doi: 10.1136/bjo.45.4.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
Karbe E., Schiefer B. Familial amaurotic idiocy in male German shorthair pointers. Pathol Vet. 1967;4(3):223–232. doi: 10.1177/030098586700400302. [DOI] [PubMed] [Google Scholar]
Koppang N. Familiäre Glykosphingolipoidose des Hundes (Juvenile Amaurotische Idiotie) Ergeb Allg Pathol Pathol Anat. 1966;47:1–43. [PubMed] [Google Scholar]
LANE R. The treatment of hepatic amoebiasis with chloroquine. J Trop Med Hyg. 1951 Oct;54(10):198–206. [PubMed] [Google Scholar]
MEIER-RUGE W. EXPERIMENTAL INVESTIGATION OF THE MORPHOGENESIS OF CHLOROQUINE RETINOPATHY. Arch Ophthalmol. 1965 Apr;73:540–544. doi: 10.1001/archopht.1965.00970030542017. [DOI] [PubMed] [Google Scholar]
OKUN E., GOURAS P., BERNSTEIN H., VON SALLMANN L. Chloroquine retinopathy; a report of eight cases with ERG and dark-adaptation findings. Arch Ophthalmol. 1963 Jan;69:59–71. doi: 10.1001/archopht.1963.00960040065013. [DOI] [PubMed] [Google Scholar]
TERRY R. D., WEISS M. Studies in Tay-Sachs disease. II. Ultrastructure of the cerebrum. J Neuropathol Exp Neurol. 1963 Jan;22:18–55. doi: 10.1097/00005072-196301000-00003. [DOI] [PubMed] [Google Scholar]
WETTERHOLM D. H., WINTER F. C. HISTOPATHOLOGY OF CHLOROQUINE RETINAL TOXICITY. Arch Ophthalmol. 1964 Jan;71:82–87. doi: 10.1001/archopht.1964.00970010098016. [DOI] [PubMed] [Google Scholar]
WHISNANT J. P., ESPINOSA R. E., KIERLAND R. R., LAMBERT E. H. CHLOROQUINE NEUROMYOPATHY. Proc Staff Meet Mayo Clin. 1963 Nov 6;38:501–513. [PubMed] [Google Scholar]
ZELLER R. W., DEERING D. Corneal complication of chloroquine (aralen) phosphate therapy. J Am Med Assoc. 1958 Dec 27;168(17):2263–2264. doi: 10.1001/jama.1958.63000170007012b. [DOI] [PubMed] [Google Scholar]

ACTIONS

PDF (6.0 MB)

RESOURCES